Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
CAMBRIDGE, MA / ACCESSWIRE / November 7, 2024 / Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the third quarter of 2024. "During the third quarter, we focused on execution with the launch of our updated COVID-19 and RSV vaccines in markets across the globe.